Kate brings 20 years of experience in the research and development of Antibody-Drug Conjugates (ADCs) to her role as Director, Program Management at Mythic Therapeutics. As a cross-functional matrix team leader, she has remarkable experience in not only communication, risk management, and problem-solving skills but also aligning to corporate goals.
